News & Press Releases

Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman recently spoke with Life Sciences Intellectual Property Review about the latest federal developments impacting the US Patent and Trademark Office, including hiring freezes, layoffs, the elimination of non-essential functions, and a return-to-office directive. The article analyzes the potential implications of the changes, particularly for pharma and biotech companies, as patent pendency times are already increasing due to a high volume of recent applications.

Michael Renaud, Chair of Mintz’s Intellectual Property Division, and Member Terri Shieh-Newton have been named finalists in Managing IP’s Americas Awards 2025. The program is the most comprehensive and widely respected IP law firm awards event in the legal industry and covers several IP practice areas and more than 50 jurisdictions.

Mintz has once again been recognized as one of the most active and high-performing International Trade Commission (ITC) law firms in the Patexia 2025 ITC Intelligence Report. 

International Life Sciences Chair Cheryl Reicin was quoted by Canadian Affairs in an article about how dental corporations have been consolidating a growing number of dental practices and the potential impacts on patients. 

ESG Practice Co-chair Jacob Hupart was quoted by Bloomberg Law in an article about how several states have introduced bills that would make large companies disclose their carbon emissions. 

Member Lauren Moldawer was quoted by Healthcare Brew on how pharmacy benefit managers (PBMs) are reacting to a proposed change to the Medicare Part D Program. This change would allow pharmacies to terminate contracts without cause and without permission from the PBM, which Lauren said could create uncertainty for PBMs.